Sam Owusu-Akyaw, president and CEO of Osteotech, said: “The ‘146 patent is an important part of our strategic vision providing patent protection for certain of our current Grafton DBM products and for our next generation DBM products currently under development. It is our patent protection that allows us to make the investments necessary to continue to develop superior products for the medical community and patient care.”